Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer
โ Scribed by (author); (author);Beesley, Jonathan (author);Pickett, Hilda (author);Johnatty, Sharon (author);Chen, Xiaoqing (author);Li, Jun (author);Rider, David (author);Stutz, Michael (author);Lambrecht, Diether (author);Chang-Claude, Jenny (author);Dork, Thilo (author);Goodman, Marc (author);Kiemmney, Bart (author);Bandera, Elisa (author);Kelemen, Linda (author);Wang-Gorke, Shan (author);Campbell, Ian (author);Gayther, Simon (author);Ramus, Susan (author);Goode, Ellen (author);Reddel, Roger (author);Chenevix-Trench, Georgia (author)
- Book ID
- 115027846
- Publisher
- Springer Nature
- Year
- 2012
- Tongue
- English
- Weight
- 83 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1897-4287
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Communicated by Stephen Chanock Matrix metalloproteinases (MMPs) play important roles in cancer initiation and development. Several polymorphisms in the promoters of a number of MMP genes, which can affect the respective MMP production in an allele-specific manner, have been well characterized.
## Abstract CYP1A1 is likely to play an important role in the etiology of CaP through its function in activating environmental procarcinogens and catalyzing the oxidative metabolites of estrogens. To test the hypothesis that genetic polymorphisms in the __CYP1A1__ gene may be associated with the ri